Bottom line
- Total investment $162K – $542K including a $49K franchise fee.
- Average unit revenue of $890K/year (median $699K).
- Rated MODERATE with a risk score of 63/100.
Item 1 · who you're contracting with
The Franchisor
Yale framework · single-unit ROIC
Returns Analysis
Pulls Item 7 (investment) and Item 19 (revenue) from this brand's FDD into the Yale unlevered-ROIC formula. Override any input to stress-test it against your own assumptions.
The model · Yale framework
What would one ScoliCare unit return on the cash you put in?
Unlevered ROIC · per unit
43%
In Yale's "attractive" band (30–60%)
Levered LBO scenario · Yale Crease Capital framing
What would 25 ScoliCare units return on equity?
Equity IRR · 5-yr
43.8%
6.15× MOIC
Year-1 DSCR
2.01×
EBITDA ÷ debt service
Equity required
$2.8M
on $11.1M purchase
Total debt
$8.3M
SBA $5.0M + senior + seller note
Overview
About
ScoliCare franchisees operate specialized clinics providing non-surgical scoliosis treatment and management services. Day-to-day operations likely involve patient consultations, treatment administration (bracing, physical therapy, monitoring), insurance billing, and patient follow-up care in a healthcare setting.
Item 7 · what it costs
The Vitals
Item 19
Financial Performance
Item 20 · unit dynamics
The Growth Chart
Year-over-year franchised unit counts and net change. Source: FDD Item 20.
Item 20 · 5 states with active franchisees
The Territory Map
Derived from franchisee contact records. Shows states with at least one current operator — not where the franchisor is registered to sell new units (that data is re-extracting in a future refresh).
States derived from franchisee phone area codes (Item 20). Approximate — ported numbers may show the original state, not the franchisee's current location.
Government records
SBA Loan Data
Aggregated from SBA 7(a) loan disclosures, public data unique to FranchiseVerdict.
No SBA loan data available for this brand.
FranchiseVerdict rating + FDD Items 3, 5, 6, 12, 17
Risk & Legal
Early-stage healthcare franchise with critical Going Concern disclosure, non-transparent profitability data, and minimal unit base raises questions about franchisor viability and franchisee ROI.
Score breakdown · what drove the 63 / 100 rating
- 01HIGHGoing Concern issue disclosed — indicates potential financial distress at franchisor level
- 02MEDNet income not disclosed in Item 19 — cannot assess actual profitability despite $890K average revenue claim
- 03MINOROnly 4 operating units with 33.3% YoY growth still represents minimal scale and unproven business model viability
- 04MEDHigh investment ceiling ($541,500) relative to disclosed average revenue ($889,959) creates thin margin for error
- 05MINOR5% royalty on gross sales (or minimum fee structure unstated) — unclear if franchisees can actually achieve profitability at claimed revenue levels
- 06HIGHNo litigation disclosed but Going Concern flag suggests potential undisclosed franchisor financial problems
Severity inferred from the FDD text · not a regulatory classification
FDD Items 5, 6, 12, 17 · continued from Risk & Legal
Contract & Territory Detail
Item 11
Training & Operations
Item 20
Franchisee Contacts
Phone numbers extracted directly from this brand's FDD Item 20. After purchase, you'll also receive a list of validation questions tailored to this brand.
Franchisee contacts
7 numbers
One-time purchase · CSV download · Validation questions included
FDD download
ScoliCare · FDD (2025) PDF